Federal News & Issues

APA Elects Dr. Jeffrey Geller as President-Elect


Jeffrey-Geller-headshot.jpg

WASHINGTON, D.C. — The members of the American Psychiatric Association (APA) have chosen Jeffrey Geller, M.D., M.P.H., as the medical society’s next president-elect. The results were released today but are not official until the APA Board of Trustees confirms the election results at its March meeting.

Geller is Professor of Psychiatry and Director of Public Sector Psychiatry at the University of Massachusetts Medical School. He has served numerous APA leadership positions, including as Area 1...

Read More
 
Author: mbourdase - Published: Feb 12, 2019

MEDIA ADVISORY: Media Encouraged to Attend APA Annual Meeting in San Francisco

WHAT:

The American Psychiatric Association's 2019 Annual Meeting features nationally recognized experts in psychiatry and mental health policy, research and clinical practice. The meeting will feature more than 650 sessions and specialized tracks, including addiction psychiatry, child and adolescent psychiatry, forensic psychiatry, geriatric psychiatry, and more. It will also include a Mental Health Innovation Zone highlighting advances in mental health technology and a special track highlighting APA’s 175th Anniversary. This year's Annual Meeting theme is Revitalize Psychiatry: Disrupt, Include, Engage & Innovate.

WHO:

... Read More
 
Author: mbourdase - Published: Feb 5, 2019

America’s Frontline Physicians Call for Texas vs. Azar Decision on Affordable Care Act to Be Reversed on Appeal

In response to the ruling to overturn the Affordable Care Act (ACA) in Texas vs. Azar, the American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College of Obstetricians and Gynecologists (ACOG), American College of Physicians (ACP), American Osteopathic Association (AOA), and American Psychiatric Association (APA), collectively representing America's frontline physicians, issued this statement:

“Our organizations, which represent more than 560,000 physicians and medical students, stand together in strong disagreement with the Texas vs. Azar decision. If upheld, this ruling would be devastating to our patients. Not only would it put coverage in jeopardy for 20 million Americans and eliminate protections for pre-existing conditions, the ruling would also:

  • End funding for...
Read More
 
Author: mbourdase - Published: Feb 1, 2019

APA Expresses Great Disappointment in the Supreme Court Decision to Lift the Injunctions on the Administration’s Ban on Transgender Servicemembers

Washington, D.C. – The American Psychiatric Association (APA) is greatly disappointed with the Supreme Court’s decision to lift the injunctions on the Administration’s ban on transgender servicemembers before all the lower court cases are decided.

“The APA continues to stand firmly against discrimination against anyone,” said APA President Altha Stewart, M.D. “We are extremely concerned that the military will discriminate against transgender Americans who want to serve their country while these lower court cases are being decided. Banning transgender service members from serving our country harms not just those transgender Americans who have dedicated themselves to service of others, but it unfairly casts a pall over all transgender Americans. And as psychiatrists, we know all too well the negative impact that...

Read More
 
Author: mbourdase - Published: Feb 1, 2019

Study Finds Increasing Use, and Misuse, of Benzodiazepines

Washington, D.C. – More than one in eight U.S. adults (12.6 percent) used benzodiazepines in the past year, up from previous reports. Misuse of the prescription drugs accounted for more than 17 percent of overall use, according to a study published online today in Psychiatric Services in Advance. The researchers defined misuse as any way a doctor did not direct, including using the drug without a prescription or more often or longer than prescribed. Misuse was highest among young adults 18 to 25 (5.6 percent) and was as common as prescribed use.

Benzodiazepines are a class of medications used to treat conditions such as anxiety and insomnia. They include Alprazolam (Xanax, Niravam) diazepam (Valium), clonazepam (Klonopin), lorazepam (Ativan) and others. Researchers analyzed data from the 2015 and 2016 National...

Read More
 
Author: mbourdase - Published: Feb 1, 2019

Pages

Mission

To advance the quality and effectiveness of psychiatric care through advocacy, professional education and camaraderie.

 

 

Contact Us

   info@ncps.org
   (415) 334-2418
   (415) 239-2533
   77 Van Ness, Suite 101, #2022
San Francisco, CA 94102